207 related articles for article (PubMed ID: 22540896)
1. A prognostic signature of defective p53-dependent G1 checkpoint function in melanoma cell lines.
Carson C; Omolo B; Chu H; Zhou Y; Sambade MJ; Peters EC; Tompkins P; Simpson DA; Thomas NE; Fan C; Sarasin A; Dessen P; Shields JM; Ibrahim JG; Kaufmann WK
Pigment Cell Melanoma Res; 2012 Jul; 25(4):514-26. PubMed ID: 22540896
[TBL] [Abstract][Full Text] [Related]
2. Defective cell cycle checkpoint functions in melanoma are associated with altered patterns of gene expression.
Kaufmann WK; Nevis KR; Qu P; Ibrahim JG; Zhou T; Zhou Y; Simpson DA; Helms-Deaton J; Cordeiro-Stone M; Moore DT; Thomas NE; Hao H; Liu Z; Shields JM; Scott GA; Sharpless NE
J Invest Dermatol; 2008 Jan; 128(1):175-87. PubMed ID: 17597816
[TBL] [Abstract][Full Text] [Related]
3. A prognostic signature of G(2) checkpoint function in melanoma cell lines.
Omolo B; Carson C; Chu H; Zhou Y; Simpson DA; Hesse JE; Paules RS; Nyhan KC; Ibrahim JG; Kaufmann WK
Cell Cycle; 2013 Apr; 12(7):1071-82. PubMed ID: 23454897
[TBL] [Abstract][Full Text] [Related]
4. Mutation analysis of genes that control the G1/S cell cycle in melanoma: TP53, CDKN1A, CDKN2A, and CDKN2B.
Soto JL; Cabrera CM; Serrano S; López-Nevot MA
BMC Cancer; 2005 Apr; 5():36. PubMed ID: 15819981
[TBL] [Abstract][Full Text] [Related]
5. The role of cell cycle regulatory proteins in the pathogenesis of melanoma.
Li W; Sanki A; Karim RZ; Thompson JF; Soon Lee C; Zhuang L; McCarthy SW; Scolyer RA
Pathology; 2006 Aug; 38(4):287-301. PubMed ID: 16916716
[TBL] [Abstract][Full Text] [Related]
6. Senescence evasion in melanoma progression: uncoupling of DNA-damage signaling from p53 activation and p21 expression.
Mackenzie Ross AD; Cook MG; Chong H; Hossain M; Pandha HS; Bennett DC
Pigment Cell Melanoma Res; 2013 Mar; 26(2):226-35. PubMed ID: 23253087
[TBL] [Abstract][Full Text] [Related]
7. Expression and significance of p53, rb, p21/waf-1, p16/ink-4a, and PTEN tumor suppressors in canine melanoma.
Koenig A; Bianco SR; Fosmire S; Wojcieszyn J; Modiano JF
Vet Pathol; 2002 Jul; 39(4):458-72. PubMed ID: 12126149
[TBL] [Abstract][Full Text] [Related]
8. Dominant effects of Δ40p53 on p53 function and melanoma cell fate.
Takahashi R; Markovic SN; Scrable HJ
J Invest Dermatol; 2014 Mar; 134(3):791-800. PubMed ID: 24037342
[TBL] [Abstract][Full Text] [Related]
9. Nucleosome assembly protein 1-like 4, a new therapeutic target for proliferation and invasion of melanoma cells.
Mizuhashi S; Fukushima S; Ishibashi T; Kuriyama H; Kimura T; Kanemaru H; Kajihara I; Makino K; Miyashita A; Aoi J; Kita K; Ihn H
J Dermatol Sci; 2021 Apr; 102(1):16-24. PubMed ID: 33583643
[TBL] [Abstract][Full Text] [Related]
10. Dual inactivation of RB and p53 pathways in RAS-induced melanomas.
Bardeesy N; Bastian BC; Hezel A; Pinkel D; DePinho RA; Chin L
Mol Cell Biol; 2001 Mar; 21(6):2144-53. PubMed ID: 11238948
[TBL] [Abstract][Full Text] [Related]
11. The p53-p21WAF1 checkpoint pathway plays a protective role in preventing DNA rereplication induced by abrogation of FOXF1 function.
Lo PK; Lee JS; Sukumar S
Cell Signal; 2012 Jan; 24(1):316-24. PubMed ID: 21964066
[TBL] [Abstract][Full Text] [Related]
12. Melanocytic nevus-like hyperplasia and melanoma in transgenic BRAFV600E mice.
Goel VK; Ibrahim N; Jiang G; Singhal M; Fee S; Flotte T; Westmoreland S; Haluska FS; Hinds PW; Haluska FG
Oncogene; 2009 Jun; 28(23):2289-98. PubMed ID: 19398955
[TBL] [Abstract][Full Text] [Related]
13. Cellular senescence in naevi and immortalisation in melanoma: a role for p16?
Gray-Schopfer VC; Cheong SC; Chong H; Chow J; Moss T; Abdel-Malek ZA; Marais R; Wynford-Thomas D; Bennett DC
Br J Cancer; 2006 Aug; 95(4):496-505. PubMed ID: 16880792
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-206 induces G1 arrest in melanoma by inhibition of CDK4 and Cyclin D.
Georgantas RW; Streicher K; Luo X; Greenlees L; Zhu W; Liu Z; Brohawn P; Morehouse C; Higgs BW; Richman L; Jallal B; Yao Y; Ranade K
Pigment Cell Melanoma Res; 2014 Mar; 27(2):275-86. PubMed ID: 24289491
[TBL] [Abstract][Full Text] [Related]
15. A Temperature Sensitive Variant of p53 Drives p53-Dependent MicroRNA Expression without Evidence of Widespread Post-Transcriptional Gene Silencing.
Cabrita MA; Vanzyl EJ; Hamill JD; Pan E; Marcellus KA; Tolls VJ; Alonzi RC; Pastic A; Rambo TM; Sayed H; McKay BC
PLoS One; 2016; 11(2):e0148529. PubMed ID: 26840126
[TBL] [Abstract][Full Text] [Related]
16. [Cyclin-dependent kinase inhibitory proteins in normal and transformed choroidal melanocytes].
Mouriaux F; Maurage CA; Labalette P; Casagrande F; Malecaze F; Darbon JM
J Fr Ophtalmol; 1999 Apr; 22(3):339-46. PubMed ID: 10337591
[TBL] [Abstract][Full Text] [Related]
17. Cell cycle checkpoint function in bladder cancer.
Doherty SC; McKeown SR; McKelvey-Martin V; Downes CS; Atala A; Yoo JJ; Simpson DA; Kaufmann WK
J Natl Cancer Inst; 2003 Dec; 95(24):1859-68. PubMed ID: 14679155
[TBL] [Abstract][Full Text] [Related]
18. Genome-Wide Overexpression Screen Identifies Genes Able to Bypass p16-Mediated Senescence in Melanoma.
Lee WJ; Škalamera D; Dahmer-Heath M; Shakhbazov K; Ranall MV; Fox C; Lambie D; Stevenson AJ; Yaswen P; Gonda TJ; Gabrielli B
SLAS Discov; 2017 Mar; 22(3):298-308. PubMed ID: 27872202
[TBL] [Abstract][Full Text] [Related]
19. E2F1-dependent oncogenic addiction of melanoma cells to MDM2.
Verhaegen M; Checinska A; Riblett MB; Wang S; Soengas MS
Oncogene; 2012 Feb; 31(7):828-41. PubMed ID: 21743494
[TBL] [Abstract][Full Text] [Related]
20. Poly(ADP-ribose) polymerase inhibition enhances p53-dependent and -independent DNA damage responses induced by DNA damaging agent.
Nguyen D; Zajac-Kaye M; Rubinstein L; Voeller D; Tomaszewski JE; Kummar S; Chen AP; Pommier Y; Doroshow JH; Yang SX
Cell Cycle; 2011 Dec; 10(23):4074-82. PubMed ID: 22101337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]